Crystalline forms of a GLP-1 receptor modulator
WO2025128561A1PCT designated stage expired Publication Date: 2025-06-19CARMOT THERAPEUTICS INC
Patent Information
- Application Number
- PCT/US2024/059368
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-12-11
- Filing Date
- 2024-12-10
- Publication Date
- 2025-06-19
Smart Images
Figure US2024059368_19062025_PF_FP_ABST
Abstract
The present disclosure relates to solid forms of a GLP-1R agonist, Compound 1. The present disclosure also relates to amorphous or crystalline forms of Compound 1 as characterized herein. The disclosure further relates to pharmaceutical compositions comprising the amorphous or crystalline forms of Compound 1 as characterized herein. The disclosure further relates to methods of treating a disease, disorder, or syndrome mediated at least in part by modulating in vivo activity of GLP-1R using the amorphous or crystalline forms of Compound 1 as characterized herein.
Need to check novelty before this filing date? Find Prior Art
Citation Information
Patent Citations
Gpcr receptor agonists, pharmaceutical compositions comprising the same, and methods for their use
WO2022165076A1
N-heterocylic GPCR receptor agonists, pharmaceutical compositions comprising the same, and methods for their use
WO2024026338A1